Gross Law Firm Announces Class Actions on Behalf of ATER, WISH and PRVB Shareholders
NEW YORK, NY / ACCESSWIRE / July 2, 2021 / The Securities Litigation Law Firm of The Gross Law Firm is issuing the following opinion on behalf of the shareholders of the following listed companies. Shareholders who have purchased shares in the following companies during the dates indicated are encouraged to contact the company regarding a possible principal applicant appointment. Appointment as principal applicant is not necessary to participate in any recovery.
Aterian, Inc. (NASDAQ: ATER)
Investors concerned: December 1, 2020 – May 3, 2021
A class action lawsuit has been brought on behalf of certain shareholders of Aterian, Inc. The filed complaint alleges that the defendants made materially false and / or misleading statements and / or failed to disclose that: (i) organic growth of the Company is in free fall; (ii) the Company’s recent self-applauded acquisitions were overpayments for faulty assets from questionable sources; (iii) Aterian’s alleged artificial intelligence software is a defective product which is of no interest to the customer; (iv) Aterian uses paid or contrived discount programs and reviews to inflate its product offerings; and (v) accordingly, the Company’s public statements were materially false and misleading at all material times.
Shareholders can find more information at https://securitiesclasslaw.com/securities/aterian-inc-loss-submission-form/?id=17342&from=1
Contextlogic Inc. (NASDAQ: WISH)
This legal action is on behalf of investors who purchased WISH in accordance with the registration statement and prospectus published as part of ContextLogic’s initial public offering on December 16, 2020 or between December 16, 2020 and May 12, 2021 .
A class action lawsuit has been brought on behalf of certain shareholders of Contextlogic Inc. In the registration statement and prospectus used to conduct the initial public offering and throughout the class action period, the defendants have made material representations. false and misleading about the soundness of ContextLogic’s business operations and financial outlook. by overestimating its Monthly Active Users (“MAU”) and MAU growth trends.
Shareholders can find more information at https://securitiesclasslaw.com/securities/contextlogic-inc-loss-submission-form/?id=17342&from=1
Provention Bio, Inc. (NASDAQ: PRVB)
Investors concerned: November 2, 2020 – April 8, 2021
A class action lawsuit has been brought on behalf of certain shareholders of Provention Bio, Inc. The filed complaint alleges that the defendants made materially false and / or misleading statements and / or failed to disclose that: (i) the license application teplizumab biologics (“BLA”) had deficiencies in the submitted form and would require additional data to obtain US Food and Drug Administration approval; (ii) as a result, teplizumab BLA lacked evidence that the Company had led investors to believe it possessed; (iii) the Company had thus overestimated the prospects for approval of teplizumab BLA and therefore the schedule for marketing teplizumab; and (iv) accordingly, the Company’s public statements were materially false and misleading at all material times.
Shareholders can find more information at https://securitiesclasslaw.com/securities/provention-bio-inc-loss-submission-form/?id=17342&from=1
The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and engage in good corporate citizenship. The company seeks redress on behalf of investors who have suffered losses when false and / or misleading statements or the omission of material information by a company lead to artificial inflation of the company’s shares. Lawyer advertising. Past results do not guarantee similar results.
The gross law firm
15 West 38th Street, 12th Floor
New York, New York, 10018
Email: [email protected]
Telephone: (212) 537-9430
Fax: (833) 862-7770
SOURCE: The gross law firm
See the source version on accesswire.com: